Detailed Stock Analysis of Juli Plc (NGX:JULI)
Company Overview
• Name: Juli Plc
• Ticker Symbol: JULI
• Exchange: Nigerian Stock Exchange (NGX)
• Date Listed: July 11, 1986
• Industry: Pharmaceutical and Consumer Goods
• Business Activities: Juli Plc is engaged in the sale of pharmaceutical products and household consumer goods. It also markets its own branded table and sachet water, known as “Juli Life Water.”
Stock Performance Overview (2024)
• Start Price (Jan 1, 2024): ₦0.59
• End Price (Dec 18, 2024): ₦10.30
• Year-to-Date Growth: 1,646% (the highest-performing stock on the NGX in 2024).
• Current Price: ₦10.30 (unchanged since July 29, 2024).
Highlights
1. Early Surge: Between February and March 2024, Juli Plc experienced an explosive 1,383% gain.
2. Peak Price: ₦10.30, achieved on July 29, 2024, following a 9% daily increase.
3. Investment Impact: An investment of ₦10,000 in January 2024 would now be worth ₦164,600.
Key Metrics (as of December 2024)
• Market Capitalization: ₦2.06 billion (0.0034% of NGX equity market capitalization).
• Shares Outstanding: 200 million.
• Price-to-Earnings (P/E): 5,859.83, reflecting an extremely high valuation due to negligible earnings.
• Price-to-Book (P/B): -3.37, indicating that liabilities far exceed assets.
• Relative Strength Index (RSI): 100, a clear signal that the stock is overbought.
Recent Trading Activity (Sep 20 – Dec 18, 2024)
• Total Volume Traded: 336,416 shares across 270 deals.
• Average Daily Volume: 5,340 shares.
• Volume High: 31,295 shares (Nov 11, 2024).
• Volume Low: 10 shares (Dec 9, 2024).
• Liquidity: Low trading volume suggests limited market depth and potential difficulty in executing large transactions.
Financial Performance (Q3 2024)
• Turnover: ₦130.84 million (up 93% from ₦67.78 million in Q3 2023).
• Cost of Sales: ₦87.51 million.
• Gross Profit: ₦43.33 million.
• Administrative Expenses: ₦2.15 million.
• Net Loss: ₦7.19 million (compared to a ₦3.63 million loss in Q3 2023).
Balance Sheet
• Total Assets: ₦94.51 million.
• Total Liabilities: ₦704.89 million.
• Equity: Negative (₦610.38 million), signaling financial distress.
Cash Flow Statement
• Operating Cash Flow: ₦18.97 million.
• Net Change in Cash: ₦-0.5 million.
Opportunities and Challenges
Opportunities
1. Industry Growth: Rising demand for healthcare products and packaged water in Nigeria provides room for expansion.
2. Brand Recognition: As an established name in pharmaceuticals and consumer goods, Juli Plc has potential to attract partnerships or funding.
Challenges
1. Financial Distress: Persistent losses and negative equity indicate solvency issues.
2. Regulatory Risks: Operating in a highly regulated sector exposes the company to compliance and operational risks.
3. Low Liquidity: Thin trading volumes make the stock highly volatile and less attractive to institutional investors.
SWOT Analysis
Strengths:
• Strong price appreciation, reflecting market interest.
• Diversified product portfolio (pharmaceuticals, sachet water, consumer goods).
Weaknesses:
• Negative equity position (₦610.38 million).
• Persistent financial losses.
Opportunities:
• Expansion in Nigeria’s growing healthcare and consumer goods market.
• Increased focus on branded products like Juli Life Water.
Threats:
• Intense market competition.
• Speculative price movement, which could lead to sharp corrections.
Investor Sentiment
While Juli Plc’s stock performance has been extraordinary, its financial performance and balance sheet are concerning. Investors should consider whether the price surge is driven by speculation rather than fundamentals.
Recommendation: Sell or Hold (Speculative)
Reasons to Sell:
1. Overvaluation: The stock price far exceeds its intrinsic value based on financial performance.
2. Financial Instability: Persistent losses and a negative equity position indicate a weak financial foundation.
3. Speculative Bubble: The explosive growth is likely speculative and may not be sustainable.
Reasons to Hold (Speculative):
Olori, [Dec 19, 2024 at 09:41]
• If you believe the company has turnaround potential and are willing to accept high risk, holding could be an option.
Conclusion:
Juli Plc’s performance in 2024 has been exceptional, but it is primarily driven by speculative trading rather than strong fundamentals. Investors with low risk tolerance should consider exiting, while risk-tolerant investors might hold for potential short-term gains.
Company Overview
• Name: Juli Plc
• Ticker Symbol: JULI
• Exchange: Nigerian Stock Exchange (NGX)
• Date Listed: July 11, 1986
• Industry: Pharmaceutical and Consumer Goods
• Business Activities: Juli Plc is engaged in the sale of pharmaceutical products and household consumer goods. It also markets its own branded table and sachet water, known as “Juli Life Water.”
Stock Performance Overview (2024)
• Start Price (Jan 1, 2024): ₦0.59
• End Price (Dec 18, 2024): ₦10.30
• Year-to-Date Growth: 1,646% (the highest-performing stock on the NGX in 2024).
• Current Price: ₦10.30 (unchanged since July 29, 2024).
Highlights
1. Early Surge: Between February and March 2024, Juli Plc experienced an explosive 1,383% gain.
2. Peak Price: ₦10.30, achieved on July 29, 2024, following a 9% daily increase.
3. Investment Impact: An investment of ₦10,000 in January 2024 would now be worth ₦164,600.
Key Metrics (as of December 2024)
• Market Capitalization: ₦2.06 billion (0.0034% of NGX equity market capitalization).
• Shares Outstanding: 200 million.
• Price-to-Earnings (P/E): 5,859.83, reflecting an extremely high valuation due to negligible earnings.
• Price-to-Book (P/B): -3.37, indicating that liabilities far exceed assets.
• Relative Strength Index (RSI): 100, a clear signal that the stock is overbought.
Recent Trading Activity (Sep 20 – Dec 18, 2024)
• Total Volume Traded: 336,416 shares across 270 deals.
• Average Daily Volume: 5,340 shares.
• Volume High: 31,295 shares (Nov 11, 2024).
• Volume Low: 10 shares (Dec 9, 2024).
• Liquidity: Low trading volume suggests limited market depth and potential difficulty in executing large transactions.
Financial Performance (Q3 2024)
• Turnover: ₦130.84 million (up 93% from ₦67.78 million in Q3 2023).
• Cost of Sales: ₦87.51 million.
• Gross Profit: ₦43.33 million.
• Administrative Expenses: ₦2.15 million.
• Net Loss: ₦7.19 million (compared to a ₦3.63 million loss in Q3 2023).
Balance Sheet
• Total Assets: ₦94.51 million.
• Total Liabilities: ₦704.89 million.
• Equity: Negative (₦610.38 million), signaling financial distress.
Cash Flow Statement
• Operating Cash Flow: ₦18.97 million.
• Net Change in Cash: ₦-0.5 million.
Opportunities and Challenges
Opportunities
1. Industry Growth: Rising demand for healthcare products and packaged water in Nigeria provides room for expansion.
2. Brand Recognition: As an established name in pharmaceuticals and consumer goods, Juli Plc has potential to attract partnerships or funding.
Challenges
1. Financial Distress: Persistent losses and negative equity indicate solvency issues.
2. Regulatory Risks: Operating in a highly regulated sector exposes the company to compliance and operational risks.
3. Low Liquidity: Thin trading volumes make the stock highly volatile and less attractive to institutional investors.
SWOT Analysis
Strengths:
• Strong price appreciation, reflecting market interest.
• Diversified product portfolio (pharmaceuticals, sachet water, consumer goods).
Weaknesses:
• Negative equity position (₦610.38 million).
• Persistent financial losses.
Opportunities:
• Expansion in Nigeria’s growing healthcare and consumer goods market.
• Increased focus on branded products like Juli Life Water.
Threats:
• Intense market competition.
• Speculative price movement, which could lead to sharp corrections.
Investor Sentiment
While Juli Plc’s stock performance has been extraordinary, its financial performance and balance sheet are concerning. Investors should consider whether the price surge is driven by speculation rather than fundamentals.
Recommendation: Sell or Hold (Speculative)
Reasons to Sell:
1. Overvaluation: The stock price far exceeds its intrinsic value based on financial performance.
2. Financial Instability: Persistent losses and a negative equity position indicate a weak financial foundation.
3. Speculative Bubble: The explosive growth is likely speculative and may not be sustainable.
Reasons to Hold (Speculative):
Olori, [Dec 19, 2024 at 09:41]
• If you believe the company has turnaround potential and are willing to accept high risk, holding could be an option.
Conclusion:
Juli Plc’s performance in 2024 has been exceptional, but it is primarily driven by speculative trading rather than strong fundamentals. Investors with low risk tolerance should consider exiting, while risk-tolerant investors might hold for potential short-term gains.